Rare & Genetic Diseases

A native Hawaiian, anthropologist, and genome scientist, Keolu Fox investigates how mutations found in indigenous populations contribute to human health and emphasizes the importance of considering who benefits from research involving indigenous genomes.

LIVE July 28th, 2021 at 2:30 PM ET
In this webinar, experts will discuss cytosine and adenosine base-editors to introduce point mutations in DNA strands without creating a breakpoint, and opportunities and considerations for using them.

Sævik measures corticosteroid levels in people with Addison’s disease to challenge the pervasive idea that these patients lose all adrenal cortex function as their disease progresses.

Fetuses transfer some of their cells to their mother in a phenomenon called microchimerism

Linda Goodman, Co-Founder and CTO of Fauna Bio, compares animal and human genomes to identify new drug targets for heart disease, obesity, and more.

A group of researchers leveraged their location to tackle questions about the rare autoimmune disorder, Addison’s disease.

Different environmental exposures, different lifestyles, and so on. So they might have different weights or different styles or even different chronic diseases.

“Gene therapy has huge potential. It has already led to cures for conditions such as spinal muscular atrophy (SMA). In the future, we will be looking at conditions like motor neurone disease, Alzheimer’s and rare cancers,”

According to the company, the new data underscore the critical importance of identifying and treating SMA as early as possible.